Search research articles
Contact Us
Filters
Showing results (201-210 of 520) with videos related to
Page
of 52
Sort By:
Plos One
|
September 19, 2019
Genetic profiling of fatty acid desaturase polymorphisms identifies patients who may benefit from high-dose omega-3 fatty acids in cardiac remodeling after acute myocardial infarction-Post-hoc analysis from the OMEGA-REMODEL randomized controlled trial
Raymond Y Kwong, Bobak Heydari, Yin Ge, et al.
European Journal of Heart Failure
|
November 2, 2010
Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction
Jens Jakob Thune, James E Signorovitch, Lars Kober, et al.
The New England Journal of Medicine
|
November 9, 2004
Angiotensin-converting-enzyme inhibition in stable coronary artery disease
Eugene Braunwald, Michael J Domanski, Sarah E Fowler, et al.
The American Journal of Cardiology
|
July 28, 2004
Clinically unrecognized Q-wave myocardial infarction in patients with diabetes mellitus, systemic hypertension, and nephropathy
David Aguilar, Samuel Z Goldhaber, Daniel J Gans, et al.
Lancet (London, England)
|
May 27, 2008
Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial
Jean-Claude Tardif, John J V McMurray, Eric Klug, et al.
JACC. Heart Failure
|
November 15, 2020
Cardiovascular and Renal Outcomes of Mineralocorticoid Receptor Antagonist Use in PARAGON-HF
Karola S Jering, Faiez Zannad, Brian Claggett, et al.
Diabetes Care
|
February 7, 2009
Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program
David Preiss, Sofia Zetterstrand, John J V McMurray, et al.
European Journal of Heart Failure
|
January 24, 2014
Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved
Jennifer K Rogers, Stuart J Pocock, John J V McMurray, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
August 13, 2017
Impact of Hyperuricemia on Long-term Outcomes of Kidney Transplantation: Analysis of the FAVORIT Study
Roberto S Kalil, Myra A Carpenter, Anastasia Ivanova, et al.
Circulation
|
December 7, 2005
Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients
Scott D Solomon, Nagesh Anavekar, Hicham Skali, et al.
Page
of 52
Search research articles
Search
Showing results (201-210 of 520) with videos related to
Sort By:
Page
of 52
Plos One
|
September 19, 2019
Genetic profiling of fatty acid desaturase polymorphisms identifies patients who may benefit from high-dose omega-3 fatty acids in cardiac remodeling after acute myocardial infarction-Post-hoc analysis from the OMEGA-REMODEL randomized controlled trial
Raymond Y Kwong, Bobak Heydari, Yin Ge, et al.
European Journal of Heart Failure
|
November 2, 2010
Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction
Jens Jakob Thune, James E Signorovitch, Lars Kober, et al.
The New England Journal of Medicine
|
November 9, 2004
Angiotensin-converting-enzyme inhibition in stable coronary artery disease
Eugene Braunwald, Michael J Domanski, Sarah E Fowler, et al.
The American Journal of Cardiology
|
July 28, 2004
Clinically unrecognized Q-wave myocardial infarction in patients with diabetes mellitus, systemic hypertension, and nephropathy
David Aguilar, Samuel Z Goldhaber, Daniel J Gans, et al.
Lancet (London, England)
|
May 27, 2008
Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial
Jean-Claude Tardif, John J V McMurray, Eric Klug, et al.
JACC. Heart Failure
|
November 15, 2020
Cardiovascular and Renal Outcomes of Mineralocorticoid Receptor Antagonist Use in PARAGON-HF
Karola S Jering, Faiez Zannad, Brian Claggett, et al.
Diabetes Care
|
February 7, 2009
Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program
David Preiss, Sofia Zetterstrand, John J V McMurray, et al.
European Journal of Heart Failure
|
January 24, 2014
Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved
Jennifer K Rogers, Stuart J Pocock, John J V McMurray, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
August 13, 2017
Impact of Hyperuricemia on Long-term Outcomes of Kidney Transplantation: Analysis of the FAVORIT Study
Roberto S Kalil, Myra A Carpenter, Anastasia Ivanova, et al.
Circulation
|
December 7, 2005
Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients
Scott D Solomon, Nagesh Anavekar, Hicham Skali, et al.
Page
of 52